Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| AEMGXAcadian Emerging Markets Investor | $35.88 | +1.85% | $1.8B | — |
| AEMZXAcadian Emerging Markets Portfolio Class I | $35.86 | +1.85% | $1.8B | — |
| ARCVXAmerican Century Investments One Choice 2030 Portfolio | $12.84 | +0.08% | $1.2B | — |
| DESIXDFA Em Mkts Sustnby Cor 1 Instl | $13.69 | +1.33% | $1.3B | — |
| ETADXEventide Dividend Opportunities A |
No one on the platform currently holds AEMGX.
No tracked institution reports a position in AEMGX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-30 | $0.5303 | 2025-12-31 |
| 2025-12-18 | $0.6602 | 2025-12-19 |
| 2024-12-30 | $0.6393 | 2024-12-31 |
| 2024-12-20 | $0.1267 | 2024-12-23 |
| 2023-12-28 | $0.7921 | 2023-12-29 |
No one on the platform has traded AEMGX yet.
| $23.12 |
| +1.00% |
| $1.4B |
| — |
| ETAHXEventide Healthcare & Life Sciences A | $56.41 | +0.20% | $1.6B | — |
| ETNHXEventide Healthcare & Life Sciences Fd Cl N | $56.91 | +0.19% | $1.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.